MEDICAL AND PEDIATRIC ONCOLOGY, cilt.36, sa.4, ss.434-441, 2001 (SCI-Expanded)
Background. With the availability of new broad-spectrum antibiotics, initial therapy with a single agent has become an alternative to classic combinations, especially beta -lactam antibiotics plus aminoglycosides, in the management of febrile neutropenic cancer patients.